Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Rayner Pharmaceuticals Ltd, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ, United Kingdom
ILUBE 5% w/v Eye Drops, Solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. A clear and colourless eye drops solution. |
Acetylcysteine 5.0% w/v.
Excipient(s) with known effect: Benzalkonium chloride 0.01% w/v.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions. |
| List of Excipients |
|---|
|
Disodium edetate |
A lipped Type I amber glass bottle with a push-in closure (chlorobutyl bung) containing 10 ml of solution. The bung is held in place by a polypropylene and aluminium overseal. The bung and overseal form a single integral closure (“flipcap”). Immediately before use, the overseal and bung are removed and replaced with a polyvinyl chloride integral cap and dropper assembly, which fits over the lip of the bottle. The integral cap and dropper assembly has an aperture at the end for the delivery of the product, which is closed with a small high density polyethylene screw cap.
Rayner Pharmaceuticals Ltd, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ, United Kingdom
PL 47069/0002
Date of first authorisation: 17 December 1992
Date of last renewal: 25 June 2007
| Drug | Countries | |
|---|---|---|
| ILUBE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.